Nazarov Pavel A
Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Antibiotics (Basel). 2022 May 30;11(6):734. doi: 10.3390/antibiotics11060734.
At present, antibiotic resistance represents a global problem in modern medicine. In the near future, humanity may face a situation where medicine will be powerless against resistant bacteria and a post-antibiotic era will come. The development of new antibiotics is either very expensive or ineffective due to rapidly developing bacterial resistance. The need to develop alternative approaches to the treatment of bacterial infections, such as phage therapy, is beyond doubt. The cornerstone of bacterial defense against antibiotics are multidrug resistance (MDR) pumps, which are involved in antibiotic resistance, toxin export, biofilm, and persister cell formation. MDR pumps are the primary non-specific defense of bacteria against antibiotics, while drug target modification, drug inactivation, target switching, and target sequestration are the second, specific line of their defense. All bacteria have MDR pumps, and bacteriophages have evolved along with them and use the bacteria's need for MDR pumps to bind and penetrate into bacterial cells. The study and understanding of the mechanisms of the pumps and their contribution to the overall resistance and to the sensitivity to bacteriophages will allow us to either seriously delay the onset of the post-antibiotic era or even prevent it altogether due to phage-antibiotic synergy.
目前,抗生素耐药性是现代医学中的一个全球性问题。在不久的将来,人类可能会面临医学对耐药细菌无能为力的局面,后抗生素时代将会到来。由于细菌耐药性迅速发展,新抗生素的研发要么成本极高,要么效果不佳。毫无疑问,开发替代方法来治疗细菌感染,如噬菌体疗法,是很有必要的。细菌对抗生素的防御基石是多药耐药(MDR)泵,它参与抗生素耐药、毒素输出、生物膜形成和持留菌形成。MDR泵是细菌对抗生素的主要非特异性防御,而药物靶点修饰、药物失活、靶点切换和靶点隔离是其第二道特异性防御防线。所有细菌都有MDR泵,噬菌体也随着它们一起进化,并利用细菌对MDR泵的需求来结合并穿透细菌细胞。对这些泵的机制及其对整体耐药性和噬菌体敏感性的贡献进行研究和理解,将使我们能够通过噬菌体 - 抗生素协同作用,要么严重推迟后抗生素时代的到来,要么甚至完全防止其出现。